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Preliminary investigation of the influence of long-term dietary isoflavone intake on 3 
reproductive tract histology and sex steroid receptor expression in female domestic 4 
cats (Felis catus) 5 
Summary 6 
Genistein and daidzein are isoflavones which are reported to influence the reproductive 7 
system in a variety of mammalian species.  This pilot study aimed to determine if dietary 8 
isoflavones could potentially influence reproductive tract histology or morphology in 9 
domestic cats, when consumed during the postnatal development period. Cats were 10 
maintained on either treatment (150 μg/g DM genistein and 150 μg/g DM daidzein, n=4) 11 
or control (isoflavone free, n=8) diets from weaning, up to 414 (± 17.2) days post-12 
weaning. Reproductive tissues were collected during routine ovario-hysterectomy and 13 
examined for histology and sex steroid receptor expression.  Findings indicate that these 14 
dietary isoflavones influenced the expression of oestrogen receptor α (ERα) and 15 
oestrogen receptor β (ERβ), and progesterone receptor in feline reproductive tissues.  One 16 
cat in the treatment group developed suppurative endometritis, but no evidence of 17 
uterotrophic or histological changes were found in any other cats. The potential to alter 18 
expression of hormone receptors in the reproductive tract of domestic cats exposed to 19 
genistein and daidzein warrants further investigation. 20 
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Introduction 24 
Dietary isoflavones are phenolic compounds found in soy and other legumes, which have 25 
oestrogenic and anti-oestrogenic properties (Kurzer and Xu, 1997). A diverse array of 26 
hormonal and non-hormonal effects have been observed in isoflavone-exposed rodents, 27 
pigs and humans, including oestrogen receptor binding, and morphological and 28 
histological changes (Barnes et al 2000; Ford et al 2006; McClain et al 2006).   29 
Domestic cats ingest, absorb, and metabolise soy isoflavones present in commercial diets 30 
(Bell et al., 2006; Cave et al., 2007). Some feline diets expose cats to isoflavone 31 
concentrations potentially capable of eliciting physiological changes (i.e. > 2 mg/kg BW) 32 
(Bell et al 2006).  The isoflavones, genistein and daidzein, comprise the isoflavones 33 
detected in the highest concentrations in commercially prepared cat food (Bell et al 34 
2006). Thus, it is important to ascertain the reproductive consequences of this level of 35 
genistein and daidzein exposure in this species. The present study was conducted to 36 
determine the potential for genistein and daidzein to alter reproductive parameters in the 37 
domestic cat, when provided at concentrations reflective of normal dietary exposure.   38 
Materials and Methods 39 
Eighteen female short-haired, domestic cats (Felis catus) were enrolled in the study and 40 
assigned to either the control group (n = 9) or treatment group (n = 9) at weaning. 41 
However, six cats were removed from the trial (two due to failure to consume the test diet 42 
within the first week, and four due to unrelated medical conditions prior to planned tissue 43 
collection).  Cats were group-housed in multi-level pens, exposed to natural day/night 44 
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cycles. At 10 weeks of age, the cats were removed from the queen’s pens, and separated 45 
into treatment (mean age 72 ± 1.89 d; BW 0.87 ± 0.07 kg) and control (mean age 71 ± 46 
2.39d; BW 0.93 ± 0.05 kg) groups. Ethical approval was obtained from the Massey 47 
University Animal Ethics Committee. 48 
The basal diet for both groups was a moist feline diet, commercially-prepared and 49 
formulated to meet the requirements for growth in the domestic cat (AAFCO 2009). This 50 
diet was assayed to contain no detectable levels of isoflavones (Bell et al., 2006). The 51 
purified (99.9%) form of each isoflavone, genistein and daidzein (LC Laboratories, MA, 52 
USA), was added to the basal diet to provide a calculated dose of 300 µg total 53 
isoflavone/g DM. Samples of the control and treatment diets were assayed for isoflavone 54 
content at monthly intervals throughout the trial according to methodology described in 55 
Bell et al. (2006). Cats were provided water ad libitum during the trial, and offered 56 
enough food to provide each cat with appropriate energy intake for age (i.e. 217 kcal/kg 57 
BW/d at eight weeks old, gradually reducing to 88 kcal/kg BW/d by 40 weeks; Legrand-58 
Defretin and Munday, 1993). Food was weighed before and after offering to each group 59 
and daily refusals were used to calculate intake per pen, which was then used to estimate 60 
intake per cat. Monthly assessments were made of individual food intake by separation of 61 
each cat into individual metabolism cages for a 24 hour period, during which time food 62 
was offered in quantities calculated to provide twice the cat’s energy needs, and food 63 
intake and urinary and faecal output were recorded. 64 
Vaginal cytology confirmed that cats were in inter-oestrous at the time of reproductive 65 
tract collection. Tissue collection was performed under halothane anaesthesia, according 66 
to standard veterinary procedures, at a mean age of 481 days (SEM 21.4) in the control 67 
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group, and 429 (SEM 62.9) in the treatment group (differences due to older cats in the 68 
treatment group being removed from the study).  Surgical procedures were performed on 69 
all cats in both groups at the same point in time (across two days) and by the same 70 
surgeon. Reproductive tracts (including ovaries, uterine horns and cervix) were weighed 71 
and ovarian surfaces examined for the presence of visible follicles, corpora lutea, and 72 
corpora haemorrhagica.  Reproductive organs were fixed in 10% buffered formalin 73 
before being processed for histology and immunohistochemical (IHC) analysis.  74 
Haematoxylin and eosin-stained slides were examined by a veterinary histopathologist 75 
(author; W.R.; blinded to treatment) and screened for abnormalities according to standard 76 
veterinary procedures.   77 
An IHC assay for assessment of ERα, ERβ and progesterone receptor (PR) was 78 
developed from the method of Martin de las Mulas et al (2000). The ERα, ERβ and PR 79 
were identified using monoclonal mouse antibodies, IgG1 (NCL-ER-6F11, NCL-ERβ; 80 
Vision Biosystems, Victoria, Australia) and PR4-12 (Merck, Palmerston North, New 81 
Zealand), respectively) validated for use in feline tissue.   82 
Histological sections were de-paraffinised and rehydrated by sequential immersion in 83 
xylene and graded alcohol baths.  Sections were microwave-heated (high power, 750W 84 
microwave oven for 7 min) in citrate buffer (10 mM citric acid, pH 6.0).  Sections were 85 
washed in phosphate-buffer solution (PBS) before non-specific binding sites in the tissue 86 
were blocked by the application of 100 µl of 10% Bovine Serum Albumin (BSA) (Roche 87 
Diagnostics, Mannheim, Germany) in ovine serum and PBS.  Sections were incubated at 88 
room temperature in a moist chamber for 45 min before BSA/serum was removed and the 89 
primary antibody applied (ERα, ERβ or PR) at dilutions confirmed in preliminary 90 
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experiments to yield optimal results (1: 50 for ERα and ERβ, 1: 30 for PR).  Sections 91 
were incubated overnight at room temperature before the primary antibody was removed 92 
and the tissues incubated with biotinylated goat, anti-mouse IgG (Invitrogen Life 93 
Technologies, Auckland, NZ) for 1 hour before a fluorescent marker was added 94 
(Streptavidin, Alexa Fluro 546 conjugate, Molecular Probes Inc., OR, USA, diluted 1: 95 
20).  Following a final incubation of 1 hour, slides were washed in cold tap water and 96 
counter-stained with haematoxylin.   97 
Positive control tissues (control cat uterine tissue and human breast cancer tissue) were 98 
incubated with each of the three primary antibodies and processed according to the same 99 
methodology as test tissues.  Tissues were examined by one investigator (author; KW-T) 100 
using 40 x magnification with epi-fluorescence illumination (488 nm), and 100 individual 101 
cells were analysed for fluorescence-staining intensity and extent using Java-based image 102 
processing software (ImageJ, version 1.38; Rasband 2007).  The level of light staining 103 
intensity detected in negative control tissue was the threshold of background 104 
luminescence used to define positive staining in test sections.   105 
For the statistical analysis, data that were not normally distributed were tested for 106 
differences between groups using the Mann-Whitney test.  For proportional data the 107 
Fisher exact test was used to compare differences.  All other parameters were tested for 108 
between-group differences using ANOVA.  All statistical procedures were carried out 109 
with Minitab software (version 15, Minitab Inc., PA, USA) with confidence limits set at 110 
95%.  111 
Results and Discussion 112 
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Four cats consumed the treatment diet and eight cats consumed the control diet for the 113 
duration of the study. By the end of the trial, treatment cats were consuming an average 114 
of 4.88 – 5.19 mg total isoflavones/kg BW/d, providing approximately equal doses of 115 
2.44 – 2.56 mg/kg BW/d of genistein and daidzein.  116 
No significant differences were observed between groups in reproductive tract wet weight 117 
(Table 1), indicating no gross morphological changes following isoflavone exposure.  118 
Table 1 here 119 
This is in contrast with previous studies in other species in which uterine hypertrophy has 120 
been reported following exposure to isoflavones in rats (Santell et al. 1997; McClain et al 121 
2005) and dogs (McClain et al. 2006).  With the exception of one cat diagnosed with 122 
subacute suppurative endometritis (discussed below), no histological abnormalities were 123 
detected in ovarian or uterine tissue from any other cat, and no histological differences 124 
were detected between treatment and control groups. The number of corpora lutea, or 125 
primary, secondary, tertiary, mature or atretic follicles in cat ovaries did not differ 126 
between groups. It is possible that the lower dose provided (reflecting the higher end of 127 
the typical dietary intake range calculated by Bell et al., 2006), and the use of an oral 128 
administration route, which results in low bioavailability (Cave et al., 2007), may explain 129 
the differences observed here compared to previous studies, whereby only dogs exposed 130 
to 500 mg/kg BW (compared to 50 mg/kg BW and 150 mg/kg BW groups) exhibited 131 
uterine hypertrophy (McClain et al., 2006). Alternatively, the duration of administration 132 
in this present study exceeds previous studies, and acute responses may have been 133 
missed. This is supported by the finding that uterine hypertrophy was detected in dogs 134 
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following 13 weeks of exposure to a high genistein dose (500 mg/kg BW) but not 135 
following 52 weeks exposure (McClain et al., 2006) 136 
However, differences detected in receptor staining between groups indicate a role for 137 
dietary isoflavones in modulating reproductive physiology in domestic cats.  Expression 138 
of ERα and ERβ receptors was greater in treated cats compared to control cats (P < 0.05), 139 
with the exception of ERα in the uterine basal endometrium and myometrium, where 140 
expression was greater in control tissues (P < 0.05; Table 2).  No difference was detected 141 
between groups in ERβ or PR expression in the myometrium.  The up-regulation of 142 
cellular expression of ERα and ERβ in the ovarian cortex, medulla and uterine 143 
endometrium observed in response to isoflavone treatment here, has been reported in 144 
other species (Jefferson et al 2002; Chrzan and Bradford 2007).  Genistein and daidzein 145 
are capable of binding to both ERs, with preferential binding and transactivation shown 146 
for ERβ (reviewed in Rietjens et al 2013). These isoflavones act as nuclear receptor 147 
ligands to enhance interactions between oestrogen-related receptors and proline-rich 148 
nuclear receptor coactivator (PNRC) (reviewed in Ricketts et al., 2005).  149 
Table 2 here 150 
Conversely, proportional expression of the PR was typically down-regulated in 151 
isoflavone-treated cat uterine and ovarian sections.  Progesterone receptor expression was 152 
lower in treatment cats compared to control cats in ovarian cortex and uterine apical 153 
endometrium (P <0.05), while no difference was detectable in the ovarian medulla and 154 
myometrium; in the uterine basal endometrium PR expression was greater in treatment 155 
cats (P < 0.05).  These sex steroid receptors are important mediators in the control of 156 
oestrogen- and progesterone-induced effects during oestrous cyclicity and pregnancy, 157 
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such that modifications at the receptor level may be reflected in aberrant physiological 158 
responses or fertility.   159 
One cat in the treatment group was diagnosed with subacute suppurative endometritis at 160 
267 days of age.  This cat’s tissue morphological data was excluded due to its diseased 161 
state.  The development of suppurative endometritis in an isoflavone-treated cat was an 162 
unexpected finding. This condition is not common in cats, and is generally only reported 163 
in cats older than eight years of age (Agudelo 2005), but further research is required to 164 
determine the role that isoflavones may have played in the onset of the condition in the 165 
cat reported here.   166 
Conclusions 167 
Preliminary findings suggest that the isoflavones, genistein and daidzein may exert 168 
modulatory effects on the expression of sex steroid receptors in feline uterine tissue. 169 
Given the limited sample size our findings should be considered as preliminary and 170 
interpreted with caution.  Future investigation should include life-time evaluation of 171 
feline fertility and fecundity, with increased sample sizes. 172 
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Table 1 Wet weights (as grams or % body weight) of reproductive tracts obtained 
from domestic cats following chronic isoflavone exposure (treatment group) or control 
animals1, 2.   
 Control group mean (SD) Treatment group mean (SD) 
 g % BW g % BW 
Entire tract wet 
weight  
1.99 (0.41) 0.07 (0.01) 2.15 (0.45) 0.07 (0.01) 
Left ovary  0.17 (0.15) 0.01 (0.00) 0.13 (0.01) 0.004 (0.00) 
Right ovary  0.12 (0.2) 0.004 (0.00) 0.11 (0.03) 0.004 (0.00) 
1Values are expressed as mean (± SD).  No significant differences were detected 
between groups (p > 0.05). 
2 Data from eight control cats and three treatment cats (one treatment cat was 
diagnosed with acute suppurative endometritis and as such the diseased state of her 






Table 2 The proportion of cells staining positive for ERα, ERβ, or PR in the reproductive tract of cats exposed to dietary genistein and 
daidzein, compared to control cats1.   
 ERα ERβ PR 
 Control Treatment Control Treatment Control Treatment 
Ovarian cortex  0.58 (0.44)a 0.79 (0.18)b 0.57 (0.46)a 0.83 (0.26)b 0.75 (0.49)b 0.66 (0.31)a 
Ovarian medulla  0.52 (0.46)a 0.94 (0.05)b 0.79 (0.21)a 0.93 (0.13)b 0.72 (0.29)a 0.76 (0.42)a 
Uterine apical endometrium  0.91 (0.13)a 0.95 (0.09)b 0.63 (0.39)a 0.88 (0.11)b 0.81 (0.30)b 0.64 (0.44)a 
Uterine basal endometrium  0.91 (0.22)b 0.84 (0.19)a 0.79 (0.33)a 0.95 (0.11)b 0.76 (0.20)a 0.88 (0.22)b 
Myometrium  0.60 (0.33)b 0.32 (0.17)a 0.53 (0.35)a 0.59 (0.22)a 0.64 (0.31)a 0.63 (0.12)a 
1Standard deviation is shown in parentheses.  Values with different superscripts (within row for each respective sex steroid receptor) 
are significantly different (p < 0.05). 
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